Also trades as: SCLXW (NASDAQ) · $vol 0M
SCLX NASDAQ
Scilex Holding Company
1W: -17.0%
1M: -24.1%
3M: -49.7%
YTD: -69.0%
1Y: -80.4%
3Y: -92.5%
5Y: -98.8%
$4.06
-0.35 (-7.94%)
Weekly Expected Move ±8.5%
$3
$4
$4
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
19 relationships0
As Filer
counterparties named
19
As Counterparty
mentioned by others
2022-03-21
Earliest Filing
2026-02-20
Latest Filing
Mentioned As Counterparty
19 mentionsOther companies that named SCLX in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| ORMP ORAMED PHARMACEUTICALS INC. | investor | Issued warrants to Oramed Pharmaceuticals Inc. in exchange for deferring an amortization payment on Senior Secured Conve | 2026-02-20 | View |
| DVLT Datavault AI Inc. | investor | Purchased 15,000,000 shares and a pre-funded warrant for $150,000,000 in BTC and entered into a License Agreement. | 2025-11-26 | View |
| DVLT Datavault AI Inc. | partner | Datavault AI Inc. entered into a License Agreement granting Scilex an exclusive, worldwide license to use patents and kn | 2025-11-05 | View |
| SMNRW Semnur Pharmaceuticals, Inc. | investor | Beneficial owner of controlling interest in New Semnur and holder of Legacy Semnur Preferred Stock. | 2025-09-26 | View |
| SCLXW Scilex Holding Co | acquirer | Parent company of Scilex, Inc. and Semnur Pharmaceuticals, Inc., selling shares of Semnur. | 2025-09-26 | View |
| SCLXW Scilex Holding Co | target | Purchased 15.0 million shares and a pre-funded warrant from Datavault for $150 million | 2025-09-26 | View |
| DVLT Datavault AI Inc. | investor | Purchased 15,000,000 shares and a pre-funded warrant for $150,000,000 in Bitcoin. | 2025-09-26 | View |
| SMNRW Denali Capital Acquisition Corp. | partner | Parent company of Semnur Pharmaceuticals, Inc. holding escrowed shares. | 2025-08-22 | View |
| SMNRW Denali Capital Acquisition Corp. | partner | Parent company of Semnur Pharmaceuticals, Inc. | 2025-07-28 | View |
| ORMP ORAMED PHARMACEUTICALS INC. | investor | Lender and warrant holder entering into an option agreement for warrant repurchase. | 2025-07-23 | View |
| SMNRW Denali Capital Acquisition Corp. | partner | Parent company of Semnur Pharmaceuticals, Inc. | 2025-04-22 | View |
| SCLXW Scilex Holding Co | partner | Parent company of Semnur Pharmaceuticals, Inc. | 2025-04-21 | View |
| ORMP ORAMED PHARMACEUTICALS INC. | partner | Counterparty in convertible notes purchase agreement and royalty purchase agreement | 2025-03-03 | View |
| ORMP ORAMED PHARMACEUTICALS INC. | partner | Parent company providing guarantee for the license agreement. | 2025-02-27 | View |
| ORMP ORAMED PHARMACEUTICALS INC. | acquirer | Target company whose equity securities are being acquired by Oramed Pharmaceuticals Inc. | 2023-08-22 | View |
| ORMP ORAMED PHARMACEUTICALS INC. | acquirer | Target company whose securities are being acquired by Oramed Pharmaceuticals | 2023-08-09 | View |
| SCLXW Vickers Vantage Corp. I | acquirer | Target company in the proposed merger with Vickers Vantage Corp. I | 2022-10-18 | View |
| SCLXW Vickers Vantage Corp. I | acquirer | Target company in the merger agreement with Vickers Vantage Corp. I. | 2022-09-14 | View |
| SCLXW Vickers Vantage Corp. I | acquirer | Target company in the merger with Vickers Vantage Corp. I; majority-owned subsidiary of Sorrento Therapeutics, Inc. | 2022-03-21 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR